citalopram has been researched along with Parkinsonian Disorders in 6 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sánchez, MG | 1 |
| Morissette, M | 1 |
| Di Paolo, T | 1 |
| Damali Amiri, N | 1 |
| Wijenaike, N | 1 |
| Navailles, S | 1 |
| Bioulac, B | 1 |
| Gross, C | 1 |
| De Deurwaerdère, P | 1 |
| Hannestad, J | 1 |
| Berriozabal Diaz, L | 1 |
| Zubiaurre Lizarralde, L | 1 |
| Castiella Eguzkiza, A | 1 |
| Zapata Morcillo, E | 1 |
| Bishop, C | 1 |
| George, JA | 1 |
| Buchta, W | 1 |
| Goldenberg, AA | 1 |
| Mohamed, M | 1 |
| Dickinson, SO | 1 |
| Eissa, S | 1 |
| Eskow Jaunarajs, KL | 1 |
6 other studies available for citalopram and Parkinsonian Disorders
| Article | Year |
|---|---|
Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Citalopram; Estradiol; Female; Macaca | 2013 |
Citalopram-induced hyponatraemia and parkinsonism: potentially fatal side-effects not to be missed.
Topics: Aged; Citalopram; Confusion; Humans; Hyponatremia; Male; Parkinsonian Disorders; Selective Serotonin | 2014 |
Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Animals; Antiparkinson Agents; Brain; Citalopram; Cobra Neurotoxin Proteins | 2010 |
Comment on "Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease".
Topics: Animals; Anti-Inflammatory Agents; Brain; Citalopram; Encephalitis; Humans; Inflammation; Lipopolysa | 2010 |
[Parkinsonism due to clebopride].
Topics: Aged; Antidepressive Agents; Antiemetics; Benzamides; Citalopram; Depression; Dyspepsia; Female; Hum | 2011 |
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskin | 2012 |